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surely warranted, as stated by Mehta and Pae. 1 Theoret- 
ically, inflow valve dysfunction may occur as well, even if 
it seems unlikely. The metallic sheath has since been 
redesigned and is now less mobile, because it is fixed to 
another metallic ring by a string. 
In conclusion, rupture of the inflow conduit close to the 
inflow valve is a life-threatening complication of the TCI 
system with the mobile cage support, which occurs more 
often than expected. Possible mechanisms include multi- 
ple bending limited by the metallic age support resulting 
from suboptimal placement, while the valvular anulus 
might be acting as an anchor. Patients with possible 
bleeding should receive aggressive treatment, even though 
exchange and replacement of the inflow conduit is a 
demanding task. The metallic sheath has recently been 
redesigned, and future patients may no longer be at risk 
for this complication. 
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NODULAR PULMONARY AMYLOIDOSIS 
Francis J. Podbielski, MD, Darren G. Nelson, MD, Gurney F. Pearsall, Jr., MD, Guillermo D. Marquez, MD, and 
Mark M. Connolly, MD, FACS, Chicago, Ill. 
Pulmonary amyloid deposition generally occurs with 
concurrent primary systemic amyloidosis. Localized forms 
of pulmonary amyloidosis are rare and appear most 
frequently as an incidental lower lobe finding in chest 
radiographs. Tissue for diagnosis can be acquired by 
bronchoscopic, omputed tomography-guided, thoraco- 
scopic, or open biopsy techniques. Our patient had a 
nonproductive cough and multiple new lung nodules that 
led to open biopsy and diagnosis. 
Although pulmonary amyloid is frequently found at 
autopsy as a sequela of primary systemic amyloidosis, 
cardiac failure resulting from amyloid deposition contrib- 
utes to the patient's death in the majority of cases. Median 
survival time for 21 patients with this condition in a series 
reported by Utz, Swensen, and Gertz 1 was 16 months. 
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Twelve percent o 25% of patients with systemic amyloid 
disease have multiple myeloma. 
Pulmonary amyloid deposition ot associated with sys- 
temic disease occurs in three anatomic distributions: 
tracheobronchial, parenchymal, and senile (or diffuse). 
Dyspnea, cough, and hemoptysis are symptoms of tra- 
cheobronchial myloidosis, with the average patient age 
being between 53 and 62 years. Management strategies 
include observation, bronchoscopic resection, laser abla- 
tion, and lung resection. The senile or diffuse form is 
generally asymptomatic. In one autopsy series 2 diffuse 
amyloidosis was present in approximately 10% of patients 
older than age 80 years and in 50% of patients older than 
age 90. The localized parenchymal form of the disorder is 
found in fewer than half of all patients with isolated 
pulmonary amyloid. 
Clinical summary. A 65-year-old woman had had a 
nonproductive cough for 2 months. She denied fever, 
night sweats, weight loss, and hemoptysis. Past medical 
history included mild hypothyroidism treated with oral 
levothyroxine, no exposure to chemicals or asbestos, 
and a history of working as a registered nurse in a 
tuberculosis anitorium in the 1950s, with a positive 
purified protein derivative (PPD) tuberculin skin reac- 
tion when last tested in 1968. A chest radiograph 
performed 4 years before presentation i preparation 
for an orthopedic procedure showed several small 
2 9 0 Brief communications 
The Journal of Thoracic and 
Cardiovascular Surgery 
August 1997 
Fig. 1. Computed tomogram of the chest with intravenous contrast material showing eccentric soft tissue 
growth around the right lower lobe lesion. 
Fig. 2. A, Photomicrograph of right lower lobe mass demonstrating replacement of lung tissue with 
acidophilic homogeneous material and scattered lymphocytes. (Hematoxylin-eosin tain; original magni- 
fication ×300.) B, Amyloid deposits how apple-green birefringence and light polarization. (Congo red 
stain; original magnification ×500.) 
calcified lung nodules with bilateral apical scarring but 
no mediastinal enlargement. 
The current chest radiograph showed a 2 cm calcified 
nodule in the right lower lobe with smaller nodules in 
the right and left upper lobes. Computed tomograms of 
the chest demonstrated the multiple aforementioned 
calcified nodules and a dominant mass in the right 
lower lobe with eccentric soft tissue growth, but no 
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evidence of mediastinal adenopathy (Fig. 1). Mammog- 
raphy demonstrated benign coarse calcifications with- 
out evidence of neoplasia. Pulmonary function tests 
yielded a forced expiratory volume at 1 second of 2.75 
L, and arterial blood gas measurements with the patient 
breathing room air showed a pH of 7.44, an oxygen 
tension of 101 mm Hg, and a carbon dioxide tension of 
33 mm Hg. The PPD skin test remained positive and 
acid-fast bacillus sputum cultures were negative. Bron- 
choscopic studies showed no abnormalities, and brush- 
ings sent for cytologic examination were negative for 
malignancy. 
After placement of a thoracic epidural infusion cath- 
eter and induction of general anesthesia with placement 
of a double-lumen endotracheal tube, a standard right 
posterolateral thoracotomy was performed through the 
fifth intercostal space. Fine adhesions between the 
upper lobe and apex were divided with cautery. Wedge 
resection of two small upper lobe nodules showed 
hyalinized, calcified granulomas on frozen section. The 
larger nodule, which was grayish red, was a poorly 
circumscribed mass formed by acidophilic staining acel- 
lular material on routine section (Fig. 2, A). Congo red 
staining of this material demonstrated apple-green bi- 
refringence and light polarization (Fig. 2, B), confirm- 
ing the pathologic diagnosis of nodular pulmonary 
amyloid deposition. 
Comment. The appearance of a new lung nodule with 
focal eccentric soft tissue growth in a patient with a history 
of tuberculosis exposure raises the possibility of scar 
carcinoma rising from a previous granuloma. Computed 
tomography-guided biopsy might have confirmed the di- 
agnosis. Its negative predictive value is low, however, and 
multiple nodules necessitating evaluation were present 
throughout the lung. Open thoracotomy provided optimal 
access for this deep parenchymal lesion and ready avail- 
ability for biopsy of other nodules. Furthermore, if a 
malignant tumor had been present, lobectomy or possibly 
pneumonectomy with lymph node dissection would have 
mandated open thoracotomy. 
Exclusion of metastatic disease in this patient's 
work-up included a thorough breast examination and 
mammogram. Results of liver function tests were within 
normal limits, and urinalysis showed no hematuria 
or proteinuria. After diagnosis of nodular amyloid 
deposition, multiple myeloma screening was per- 
formed; urinary assay for Bence-Jones proteins was 
negative. The finding of normal blood gases and pul- 
monary function suggested against interstitial lung 
disease. 
Treatment of nodular pulmonary amyloidosis as an 
isolated disease entity has been described in surgical 
reports,3.4 and such nodules have occurred in patients 
with cardiac amyloid s and after heart transplantation 
for cardiac amyloid. 6Although solitary pulmonary pa- 
renchymal amyloid deposits have an overall benign 
course, those lesions located in the tracheobronchial 
tree often require laser resection and occasionally 
lobectomy. Large symptomatic amyloid deposits com- 
pressing adjacent mediastinal structures might also 
require excision. 
Should isolated pulmonary amyloid deposits in the 
absence of systemic disease be treated with surgical 
resection? Even if a lesion is amenable to transbron- 
chial biopsy, the diagnosis of pulmonary amyloid does 
not preclude existence of coexisting local or systemic 
malignant disease. The presence of amyloid serves only 
as a nonspecific marker of abnormal tissue metabolism 
and should alert the surgeon to the need for further 
diagnostic evaluation and open resection. 
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